Direct-to-Consumer genetic testing: what are we talking about? (Q43577480)

24 November 2017

title

Direct-to-Consumer genetic testing: what are we talking about? (English)

1 reference

24 November 2017

Meredith Weaver

1

1 reference

24 November 2017

Toni I Pollin

series ordinal

2

1 reference

24 November 2017

publication date

10 March 2012

1 reference

Journal of Genetic Counseling

24 November 2017

published in

1 reference

24 November 2017

volume

21

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

361-366

1 reference

Genetics of type 2 diabetes.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Effect of direct-to-consumer genomewide profiling to assess disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

What is the clinical utility of genetic testing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Cancer genetic counselees' self-reported psychological distress, changes in life, and adherence to recommended surveillance programs 3-7 years post counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Effects of individualized breast cancer risk counseling: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Personal genomes: The case of the missing heritability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Genetic risk profiling for prediction of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10897-012-9493-Y

Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

21 January 2018

1 reference

12 December 2020

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis

1 reference

12 December 2020

Genetic counseling for women with an intermediate family history of breast cancer

1 reference

12 December 2020

The prospect of predictive testing for personal risk: attitudes and decision making

1 reference

12 December 2020

Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices

1 reference

12 December 2020

The duration of ambulatory visits to physicians

1 reference

12 December 2020

10.1007/S10897-012-9493-Y

Identifiers

DOI

1 reference

24 November 2017

1 reference